Latest news
24.06.2019
DNV3681's exceptional activity against bioterrorist threats presented at ASM Microbe 2019
Major Steven Zumbrun (USAMRIID [1] , U.S. Department of Defense) presented data on the in vitro assessment of DNV3681 against pathogens...
11.06.2019
DEINOVE and AVRIL completing the development of a natural feed additive
The tests aimed at validating the dosage required have confirmed a very good efficacy of the ingredient The teams are working to develop a...
05.06.2019
DEINOVE & Dow sign a collaboration agreement for the development of a new cosmetic active ingredient
Dow has selected an extract belonging to the DEINOVE proprietary strains’ bank to launch a new cosmetic active ingredient for skin care...
Press Coverage
30.04.2019
Labiotech.eu | Life at its Limits: Meet the Extremophiles Being Embraced by the Biotech Industry
French biotech Deinove has an enviable collection of thousands of species of rare microbes that the company has been collecting since it...
19.03.2019
Arte | Antibiotiques, la fin du miracle ?
Le XXIe siècle marquera-t-il la fin de l’ère des antibiotiques, ramenant la médecine deux cents ans en arrière ? Malgré leurs efforts, les...
18.03.2019
France Inter | Grand bien vous fasse | Vices et vertus des antibiotiques
Ecoutez le replay de l'émission Ali Rebeihi invite 3 spécialistes pour discuter des défis sanitaires que pose le développement accéléré des...